Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG for Sentinel Lymph Node Identification in Colonic Cancer
NCT01662752Phase 2Completed
- Sponsor
- Imperial College London
- Start
- May 2013
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of indocyanine green in colon cancer, sponsored by Imperial College London. Primary endpoint: Subjects in Which the Sentinel Lymph Nodes Are Identified at 28 days. Started May 2013; status: completed.
02
Drugs
indocyanine green
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT01662752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01662752.